Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency. (October 2018) - Taylor, Ronald; Lindorfer, Margaret; Oostindie, Simone; Cook, Erika; Zent, Clive; Burack, Richard; Beurskens, Frank; Schuurman, Janine; Breij, Esther; Parren, Paul